Speaker Profile
Biography
Dr. Hinrichs is a physician-scientist who has pioneered cell therapy for HPV-associated and other epithelial cancers. He discovered tumor-infiltrating lymphocyte therapy for HPV-associated cancers, the first cell therapy to produce durable complete responses in epithelial cancers. He also discovered gene-engineered TCR-T cell therapies targeting HPV antigens and demonstrated their safety and clinical activity. His laboratory focuses on T-cell receptor discovery, next-generation cell therapies, and mechanisms of response to immunotherapy. At Rutgers Cancer Institute, he leads a bench-to-bedside-and-back cell therapy program that uses the Cell Therapy Research Laboratory, Process Development Laboratory, and GMP Facility to bring new treatments to patients in New Jersey. Clinical trials with on-site GMP manufacturing include therapies for gastric, lung, breast, cervical, oropharyngeal, anal, and other genital cancers.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.